In our previous study, He et al. (He et al. 2022) demonstrate that inhibition of a specific member of cathepsin (cathepsin-L) leads to improved cardiac function and reduced infarct size in an ex vivo rat model of myocardial ischemia/reperfusion injury. This evidence concerns the gene CTSS and myocardial ischemia.